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ABSTRACT
Translational control through programmed riboso-
mal frameshifting (PRF) is exploited widely by
viruses and increasingly documented in cellular
genes. Frameshifting is induced by mRNA secondary
structures that compromise ribosome fidelity during
decoding of a heptanucleotide ‘slippery’ sequence.
The nsp2 PRF signal of porcine reproductive and
respiratory syndrome virus is distinctive in direct-
ing both −2 and −1 PRF and in its requirement for a
trans-acting protein factor, the viral replicase subunit
nsp1. Here we show that the the trans-activation
of frameshifting is carried out by a protein complex
composed of nsp1 and a cellular poly(C) binding
protein (PCBP). From the results of in vitro trans-
lation and electrophoretic mobility shift assays, we
demonstrate that a PCBP/nsp1 complex binds to
a C-rich sequence downstream of the slippery se-
quence and here mimics the activity of a structured
mRNA stimulator of PRF. This is the first description
of a role for a trans-acting cellular protein in PRF. The
discovery broadens the repertoire of activities asso-
ciated with poly(C) binding proteins and prototypes
a new class of virus–host interactions.
INTRODUCTION
In programmed −1 ribosomal frameshifting (−1 PRF),
mRNA signals induce a proportion of translating ribo-
somes to slip back by 1 nucleotide (nt) into an overlapping
open reading frame (ORF) and to continue translation, al-
lowing the coordinated expression of two or more proteins
from a single mRNA (1–3). First described as the mech-
anism by which the Gag-Pol polyprotein of the retrovirus
Rous sarcoma virus (RSV) is expressed from overlapping
gag and pol ORFs (4), related −1 PRF signals have been
documented in many other viruses of clinical, veterinary
and agricultural importance (reviewed in Ref. 5). PRF has
also been increasingly recognized in conventional cellular
genes of both prokaryotes and eukaryotes as well as in other
replicating elements, such as insertion sequences and trans-
posons (6,7).
Central to almost all examples of −1 PRF is the inter-
action of the ribosome with a stimulatory mRNA struc-
ture (a stem-loop or RNA pseudoknot) which promotes
frameshifting on a stretch of homopolymeric bases known
as the slippery sequence. How these RNA structures act is
incompletely understood, but accumulating evidence sup-
ports the view that by presenting an unusual topology
(1,2,8–11) they confound an intrinsic unwinding activity of
the ribosome with consequent effects on the elongation cy-
cle and framemaintenance (12–14). Indeed, kinetic analyses
in bacterial systems indicate that stimulatory RNAs can im-
pair movements of the ribosomal small subunit (30S) head,
delaying dissociation of EF-G and the release of tRNA
from the ribosome (15–17).
Recently, we identified a novel, highly efficient −2/−1
PRF event that functions without a recognizable stimula-
tory RNA secondary structure (18,19). This signal oper-
ates during translation of the genome of porcine reproduc-
tive and respiratory syndrome virus (PRRSV), a member
of the familyArteriviridae in the orderNidovirales (20). The
PRRSV genome (Figure 1), a positive-sense RNAmolecule
some 15 kb in length, harbours two PRF signals. A ‘canoni-
cal’−1 PRF element, including a stimulatoryRNApseudo-
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Figure 1. Stimulation of PRRSV−2/−1 PRF in vitro in RRL. (A) The∼15-kb PRRSV genome has two long 5′ ORFs, 1a and 1b encoding non-structural
polyproteins (nsps) and at least eight shorter 3′ ORFs (2a-7) encoding structural proteins. ORF1a and ORF1b are translated from the genomic RNA,
with translation of ORF1b depending on −1 PRF at the end of ORF1a. The TF ORF overlaps the central ORF1a region in the −2 reading frame and is
accessed via −2 PRF (18). A −1 frameshift at the same site generates the nsp2N product. Shown below is the sequence of the SD01-08 RNA in the region
of the −2/−1 PRF signal, with the slippery sequence (purple) and C-rich motif (red) highlighted. The −1 reading frame stop codon is underlined and
codons for each of the reading frames are indicated. (B) Crystal structure of the PRRSV nsp1 dimer (32). The putative RNA binding domain is in orange
(see text). (C) RNAs derived from FspI-cut pDluc PRRSV/wt, or a variant with the −1 frame stop codon (panel A) changed to UUA (PRRSV/stop),
were translated in RRL in the presence of the indicated concentrations of His-tagged nsp1 (M) or with nsp1 dilution buffer (DB). The products were
resolved by 12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by autoradiography. 14C molecular size markers
were also run on the gel (M). Products generated by ribosomes that do not frameshift (stop) or that enter the −1 or −2 frames are indicated. The asterisk
indicates the −1 PRF product of the PRRSV/wt construct. (D) In vitro translation of pDluc PRRSV/wt mRNA in the presence of 1 M GST-nsp1
or mutant derivatives (PR, RBM; see text). Control translations were supplemented with an equivalent concentration of expressed GST or DB alone.
Translation products were analysed and quantified as above (C).
knot structure, is located at the junction of the overlapping
replicase-encoding ORFs 1a and 1b and facilitates expres-
sion of an ORF1a-ORF1b fusion product. The second sig-
nal, which stimulates both −2 PRF and −1 PRF, is located
within the region of ORF1a that encodes a large, multifunc-
tional replicase subunit, non-structural protein 2 (nsp2).
Here, about 20% of ribosomes translating nsp2 frameshift
into the −2 reading frame to generate a transframe fusion
protein (nsp2TF) comprising the N-terminal two-thirds of
nsp2 and a C-terminus derived from a conserved, overlap-
ping ORF (transframe; TF) in the−2 reading frame. A fur-
ther 7% of ribosomes shift into the −1 reading frame where
they immediately encounter a stop codon resulting in the
synthesis of a truncated version of nsp2 termed nsp2N (19).
As shown in Figure 1A, the RNA downstream of the slip-
pery sequence (GG GUU UUU) used for −2/−1 PRF in
PRRSV does not harbour an obvious secondary structure
compatible with canonical RNA-structure-stimulated PRF.
However, mutations within a conserved CCCANCUCC
motif located 11 nt downstream of the shift site reduce or
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inhibit frameshifting, consistent with the presence of a 3′
stimulatory element of some form (18). A further novelty of
the PRRSV −2/−1 PRF signal is an essential role for the
25-kDa viral replicase subunit nsp1, which functions as a
trans-activator of both −2 and −1 PRF (Figure 1B) (19).
Nsp1 is one of the 14 subunits produced from the PRRSV
replicase polyproteins. How it acts in PRF is unclear but
replacement of basic residues within a highly conserved pu-
tative RNA-binding motif located in the papain-like auto-
proteinase (PLP) domain of nsp1 have a detrimental effect
on frameshifting (19).
Through reconstitution of the PRRSV −2/−1 PRF sig-
nal in vitro, we show here that in addition to the viral trans-
activator nsp1, efficient frameshifting requires the partic-
ipation of cellular poly(C) binding proteins (PCBPs). In
mammalian cells, two PCBP subsets have been described,
hnRNPs K/J (21) and the CP proteins CP1 and CP2,
often referred to as PCBP1 and PCBP2 (22,23). The lat-
ter group also includes the more recently described par-
alogues PCBP3 and PCBP4 (24). PCBPs are members of
the KH domain superfamily of nucleic acid binding pro-
teins and have a wide spectrum of biological activities, in-
cluding the regulation of RNA splicing, the stabilization of
cellular and viral mRNAs, transcriptional activation and
inhibition, and translational silencing and enhancement (re-
viewed in Refs. 25,26). Using in vitro translation and RNA
binding assays, we demonstrate that a complex of nsp1
and PCBP binds to the RNA downstream of the slippery
sequence and mimics the action of the more typical RNA
pseudoknot stimulators of programmed frameshifting. This
unprecedented frameshift-stimulatory signal provides new
insights as to how the ribosomal elongation cycle can be
modified by trans-acting protein factors. Further, it broad-
ens the repertoire of activities associated with poly(C) bind-
ing proteins and prototypes a new class of virus–host inter-
actions.
MATERIALS AND METHODS
Plasmids
Assessment of in vitro frameshift efficiencies employed
pDluc/PRRSV wt and mutant derivatives. This vector
contains the GG GUU UUU shift site, 5 upstream nu-
cleotides (nt) and 66 downstream nt (79 nt in total) inserted
between Renilla and firefly luciferase reporter genes of
plasmid pDluc (27) such that −2 PRF is required for
firefly luciferase expression. Protein expression vectors
were as follows. PCBPs were cloned into pQE30 (Qiagen)
at the BamH1/HindIII (PCBP1, 2, 3) or Sph1/HindIII
(PCBP4) sites. Human PCBP1 (NM 006196.3) and
PCBP2 (NM 005016.5) in pQE30 were kindly provided
by Professor B. Semler, University of California, Irvine.
PCBP3 (NM 021568.2 and XM 006513919.2) and PCPB4
(NM 033008.2 or XM 006713271.1) were obtained by
reverse transcriptase-polymerase chain reaction (RT-PCR)
using purified mRNA from mouse BV2 and human HeLa
cells, repectively. Human hnRNP K/J (NM 002140.3; de-
rived from HeLa cell mRNA by RT-PCR) was cloned into
BamH1/XhoI-cut pET21a (Novagen). Nsp1 was cloned
into BamH1/HindIII-cut pQE30 and BamH1/XhoI–cut
pGEX6P2 (GE Healthcare). For analysis of ribosomal
pausing, a 39-bp region of the PRRSV PRF region (with
defective slippery sequence GGUAUUC, flanked by wild-
type (WT) sequences comprising 5 nt upstream and 27
nt downstream) was cloned into the XhoI/PvuII sites
of pPS0 (28). Assessment of PRF efficiencies in cultured
cells employed pL-nsp1-2, which encodes a self-cleaving
nsp1-nsp2 polyprotein under the control of a T7 promoter
(19). Poliovirus P3/Leon/37 (accession number K01392.1)
IRES SLIV was prepared by polymerase chain reaction
(PCR) from plasmid pGemCat/PVIRES/Luc (kind gift of
Dr Graham Belsham) and cloned into BamH1/EcoR1-cut
pcDNA3.1 (Thermo Fisher Scientific).
Protein expression and purification
N-terminally hexahistidine-tagged proteins expressed in
pQE30 or pET21a were purified from Escherichia coli TG1
or BL21/DE3/pLysS cells. Single colonies were picked
into Luria-Bertani broth and grown at 37◦C to an OD600
of 0.6. Protein expression was induced by addition of
isopropyl -D-1-thiogalactopyranoside (to 0.1 mM) and
continued for 2 h at 37◦C (or overnight at 22◦C) after
which cells were pelleted and resuspended in lysis buffer
(20 mM Tris, pH 7.5, 20 mM imidazole, 0.5 mM MgCl2,
1.4 mM 2-mercaptoethanol, 0.05% Tween 20, 500 mM
NaCl, 0.1 mg/ml lysozyme). Cells were incubated on ice
for 30 min and sonicated to complete lysis. Protein pu-
rification was performed using Ni-nitrilotriacetic acid (Ni-
NTA; Qiagen) according to standard procedures (29). N-
terminally glutathione-S-transferase (GST)-tagged nsp1
was expressed in BL21/DE3/pLysS cells as above and pu-
rified using glutathione agarose resin (ThermoFisher Scien-
tific) according to standard procedures (30). Proteins were
dialysed against 50 mM Tris, pH 7.5, 100 mM KCl, 1 mM
dithiothreitol (DTT), 0.05 mM ethylenediaminetetraacetic
acid (EDTA) and 5% glycerol, quantified by bicinchoninic
acid assay (Pierce) and stored at −80◦C until required.
In vitro translation
Frameshift reporter plasmids were linearized with FspI and
capped run-off transcripts generated using T7 RNA poly-
merase as described (31). Messenger RNAs were trans-
lated in nuclease-treated rabbit reticulocyte lysate (RRL)
or wheat germ (WG) extracts (Promega) programmed with
∼50 g/ml template mRNA. Typical reactions were of 10
l volume and composed of 90% (v/v) RRL, 20 Mamino
acids (lacking methionine) and 0.2 MBq [35S]-methionine.
Reactions were incubated for 1 h at 30◦C and stopped by
the addition of an equal volume of 10mM EDTA, 100
g/ml RNase A followed by incubation at room temper-
ature for 20 min. Samples were prepared for sodium do-
decyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) by the addition of 10 volumes of 2×Laemmli’s sam-
ple buffer, boiled for 4 min and resolved by SDS-PAGE.
Dried gels were exposed to a Cyclone Plus Storage Phos-
phor Screen (PerkinElmer), the screen scanned using a Ty-
phoon TRIO Variable Mode Imager (GE Healthcare) in
storage phosphor autoradiography mode and bands were
quantified using ImageQuantTMTL software (GE Health-
care). The calculations of frameshifting efficiency (%FS)
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took into account the differential methionine content of
the various products and %FS was calculated as % −1FS
= 100 × [IFS1/MetFS1) / [IS/MetS + IFS1/MetFS1) +
IFS2/MetFS2)] and similarly for % −2FS. In the formula,
the number of methionines in the stop, −1FS and −2FS
products are denoted by MetS, MetFS1 and MetFS2 re-
spectively; while the densitometry values for the same prod-
ucts are denoted by IS, IFS1 and IFS2, respectively. All
frameshift assays were carried out aminimumof three times
and the measured frameshift efficiencies (±SEM) are pro-
vided in the Supplementary Data.
Ribosome pausing assays
WG in vitro translation reactions (30l) were supplemented
with 1 M nsp1, PCBP2 (or KH mutant derivative) or
both proteins and programmed with mRNAs derived from
AvaII-cut pPS0/PRRSV WT or pPS0/PRRSV CC2. Re-
actions were incubated at 18◦C for 5 min prior to addi-
tion of edeine to 5 M. Aliquots (1.5 l) were subsequently
withdrawn at intervals post-edeine addition, mixed with an
equal volume of 10mM EDTA, 100 g/ml RNase A and
placed on ice. At the end of the time-course, samples were
analysed by SDS-PAGE.
Electrophoretic mobility shift assay (EMSA)
Short, 32P-labelled template RNAs (58 nt) containing the
PRRSV PRF region (with slippery sequence precisely at
the 5′ end and C-rich region towards the centre) were pre-
pared by T7 transcription of a PCR product generated
using primers flanking the frameshift region, with the 5′
primer containing the T7 polymerase promoter sequence.
Test proteins were diluted where necessary in dilution buffer
(DB) (5 mM Tris pH 7.5, 100 mM KCl, 1 mM DTT, 0.05
mM EDTA, 5% glycerol) and added to reactions (10 l fi-
nal volume) alongside electrophoretic mobility shift assay
(EMSA) buffer (10 mMHepes pH7.6, 150 mMKCl, 2 mM
MgCl2, 1 mM DTT, 0.5 mM adenosine triphosphate, 5%
glycerol, 100 g/ml porcine tRNA, 10U RNase inhibitor
per ml), after which the radiolabelled probe was introduced.
After incubation at 30◦C for 10 min, samples were loaded
promptly onto 4% acrylamide non-denaturing gels (acry-
lamide:bisacrylamide ratio 10:1) and run at 175V at room
temperature until free and bound RNA species were re-
solved. Gels were fixed for 15 min in 10% acetic acid, 10%
methanol, dried and exposed to X-ray film.
Pull down assays
For each protein tested, 40 l of a 50% suspension of
glutathione-agarose beads was centrifuged (500 g, 5 min),
the supernatant removed and the beads washed sequentially
with 200 l water and thrice with GST wash buffer (50 mM
Tris pH 7.6, 100 mMKCl, 5 mMMgCl2, 1 mMDTT). Fol-
lowing incubation with nsp1 (6 g) for 1 h at 4◦C on a ro-
tating wheel, the protein was removed and the beads washed
three times with GST wash buffer. Test protein (2 g) was
added to the beads and the incubation andwashing steps re-
peated, with the GST wash buffer supplemented with 0.1%
NP-40. After removal of the final wash, 25l 4×Laemmli’s
sample buffer was added, the beads boiled for 5 min and su-
pernatants analysed by SDS-PAGE.
siRNA-mediated knockdown
Details are provided in Supplementary Data.
RESULTS
Reconstitution of the PRRSV −2/−1 PRF signal in vitro
Trans-activation of PRRSV−2/−1 PRF by nsp1 was pre-
viously demonstrated by co-expression of nsp1 and nsp2
in cultured cells and by site-directed mutagenesis of the vi-
ral genome (18,19). To study the phenomenon in vitro, a
79-bp fragment encompassing the slippery sequence and C-
rich region was subcloned between the Renilla and firefly
luciferase genes of a frameshift-reporter plasmid (pDluc)
such that expression of the downstream cistron (fluc) was
dependent upon −2 PRF within the inserted PRRSV se-
quences. In RRL in vitro translations, mRNAs transcribed
from pDluc/PRRSV specified the synthesis of only the
product of the 5′ cistron of the reporter mRNA (Rluc) and
no frameshifting was evident (Figure 1C). However, sup-
plementation with recombinant, purified His-tagged nsp1
yielded two additional proteins, the most abundant corre-
sponding to the product of−2 PRF. The second protein mi-
grated more rapidly than that of Rluc and we surmised that
this protein corresponded to the product of a −1 PRF, as a
−1 frame stop codon is present immediately downstream of
the slippery sequence (underlined in Figure 1A). To confirm
this, the−1 frame stop codon (UGA)was changed toUUA,
which extends the −1 reading frame by 56 codons and si-
multaneously introduces a 0-frame stop codon UAA thus
shortening the Rluc gene. As expected, this point mutation
increased the size of the predicted −1 PRF product, and
slightly reduced the size of the Rluc protein (stop). These
experiments indicate that the 79-nt region cloned into pD-
luc likely contains all of the cis-acting elements required for
PRRSV −2/−1 frameshifting and that supplementation of
the RRL translations with nsp1 alone is sufficient to trans-
activate frameshifting to levels similar to those seen in in-
fected cells (−2 PRF, 17%; −1 PRF, 7%; see Supplemen-
tary Table). The stimulation of PRF by nsp1 was specific
to the PRRSV signal in that the protein had no effect on
frameshifting at a variety ofwell-established sites of viral−1
PRF (Supplementary Figure S1). Furthermore, the protein
was unable to promote stop codon readthrough at variants
of the PRRSV signal with an in-frame stop codon placed
within the slippery sequence at the position that would be
decoded in the peptidyl- (P) or aminoacyl- (A) site of the
ribosome (Supplementary Figure S1).
The crystal structure of nsp1 (Figure 1B) reveals an
overall ellipsoidal structure consisting of six -helices and
seven -strands with two major domains, a 48-amino-acid
N-terminal domain (NTD) and a C-terminal papain-like
cysteine protease (PLP1) domain (32). Within the lat-
ter domain, we previously identified a conserved motif
123GKYLQRRLQ131 (19) as a potential RNA binding mo-
tif (RBM) that forms one of three  helices in the region
between the catalytic residues of PLP1 (C96 and H165;
Ref. 19). To investigate the importance of these activities to
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trans-activation of PRF, amino acid substitutions were in-
troduced into the protease active site (C96S; PR) or within
the putative nsp1 RBM (K124A/R128A, mutant RBM;
previously described as mutant 1KO (Li et al., (19)) and
the expressed variants tested in RRL (Figure 1D). In this
experiment, the protease-defective variant retained full ac-
tivity, ruling out the involvement of the protease activity of
nsp1 in the stimulation of PRF. In contrast, the RBMmu-
tation prevented frameshifting, supporting a role for RNA
binding by nsp1.
A requirement for Poly(C) binding proteins in PRRSV
−2/−1 PRF
To assess the role in PRF of sequences 3′ of the slippery
sequence, a series of in-frame deletions were introduced
into pDluc/PRRSV, starting from the 3′ end of the inserted
PRRSV sequence. RNAs transcribed from these plasmids
were translated in RRL in the presence of nsp1 (Figure
2A). PRF was found to be unaffected until the length of
the PRRSV sequence downstream of the slippery sequence
fell below 21 nt, at which point PRF was reduced (18 nt)
or abolished (15 or 9 nt). In the latter constructs, the C-rich
region is compromised, consistent with an important role
in PRF. Similar results were previously observed in trans-
fected cultured cells (Li et al., (19)). To investigate the func-
tion of the C-rich region specifically, we prepared a library
of individual point mutations within, and flanking, the C-
rich region and assessed their effect on PRF (Figure 2B).
It was found that changing any of the C residues to G had
a detrimental effect on PRF, with the exception of the fi-
nal residue (C13, 3′ of the conserved sequence), where the
effect was more modest. As an explanation for these ob-
servations, we speculated that the RNA downstream of the
slippery sequence may interact with PCBPs. The ‘minimal’
region of PRRSVRNA required for full activity in PRF (21
nt) has only two C-rich patches, whereas previously estab-
lished PCBP-binding consensus sequences more commonly
have three (or more) C-triplets, potentially with each triplet
binding oneKHdomain ((33); see below).However, PCBP1
and PCBP2 are amongst several candidates reported to as-
sociate withGST-tagged nsp1 in association screens, and a
direct physical interaction between the two has been shown
(34,35). PCBPs could therefore bind to the PRRSVmRNA
by virtue of an association with nsp1.
To explore the potential role of PCBPs in PRRSV PRF,
we translated the pDluc/PRRSVmRNA in RRL reactions
supplemented with nsp1, His-tagged human PCBP2, or
both proteins (Figure 3A). We found that PCBP2 alone
did not affect PRF (right hand lane), but when added to-
gether with nsp1, synthesis of the −1 PRF product was
stimulated some 3-fold (see Supplementary Table). We rea-
soned that if the ‘active’ trans-acting stimulator of PRF in
PRRSV is a complex of nsp1 and PCBP, the RRL sys-
tem may already contain an abundant form of PCBP, but
one which would, in complex with nsp1, preferentially in-
duce −2 PRF. In this experiment, supplementation with
PCBP2 may have generated nsp1–PCBP2 complexes that
could preferentially promote −1 PRF. We therefore trans-
lated the PRRSV frameshift reporter mRNA in the WG in
vitro translation system on the basis that this lysate might
contain fewer endogenous PCBPs, or PCBPs of sufficient
evolutionary divergence to preclude any interactions with
nsp1. Consistent with our hypothesis, PRF at the PRRSV
signal in WG was found to be completely dependent upon
the addition of both nsp1 and PCBP2, with neither pro-
tein alone having any frameshift-stimulatory activity in this
system (Figure 3B). Further, supplementation ofWG trans-
lations with PCBP2 led preferentially to a−1 PRF, whereas
with humanPCPB1,−2 PRFwasmost evident (Figure 3C),
suggesting that the abundant form in RRL is PCBP1. We
also tested mouse PCBP3, human PCBP4 and mouse hn-
RNP K/J in WG translations (Figure 3C and D). Of these
three proteins, only PCBP3 was able to promote frameshift-
ing, with both−2 and−1 PRF products observed at similar
levels (Figure 3C).We confirmed the involvement of PCBP1
and 2 in frameshifting in cultured cells using siRNAs (Sup-
plementary Figure S2). Knockdown of PCBPs individually
or together substantially reduced PRF, with PCBP1 notice-
ably affecting −2 PRF, and PCBP2, −1 PRF, consistent
with the results of the WG assays above. No effect on PRF
was seen with siRNAs targeting PCBP3, PCBP4 or hnRNP
K/J, although we could not verify knockdown of PCBP3
due to lack of a reactive antibody.
Synergistic binding of nsp1 and PCBP to the PRRSV
−2/−1 PRF signal
RNA binding by the PRRSV PRF trans-activators was
investigated using EMSAs. A short (58 nt) 32P-labelled
transcript encompassing the minimal PRRSV frameshift-
stimulatory region was incubated with nsp1, PCBP1 (or
PCBP2) or both proteins, prior to electrophoresis on a
4% non-denaturing polyacrylamide gel. As shown in Fig-
ure 4A, a single RNA–protein complex was observed, the
formation of which required both nsp1 and PCBP1 (or
PCBP2). Using a broader range of PCBP2 concentrations
at saturating levels of nsp1, the estimated Kd of the inter-
action was found to be 130 nM (Supplementary Figure S3).
In the presence of PCBP2, the PRmutant of nsp1was able
to bind the target RNA indistinguishably from theWT pro-
tein, but the RBM mutant gave a smeary pattern, indica-
tive of weak, non-specific, RNA binding (Supplementary
Figure S3). As a control, a version of the RNA probe mu-
tated in the C-rich region (CC2, Ref. 18) was also tested,
and no nsp1/PCBP2 binding was evident (Supplementary
Figure S3). A supershift assay was carried out to confirm
nsp1 and PCBP association with the RNA in the complex.
The PRRSV RNA was incubated with nsp1 and PCBP2
and subsequently with specific antibodies targeting either
protein prior to EMSA. As shown in Figure 4B, in lanes
from reactions with an added anti-PCBP2 monoclonal an-
tibody, an additional band of slower mobility was seen con-
sistent with the presence of PCBP2 in the RNA/protein
complex. A monoclonal antibody targeting the NTD of
nsp1 did not yield a novel EMSA product, but a more
slowly migrating species was observable with a polyclonal
anti-nsp1 serum. These observations support the view that
the RNA/protein complex seen contains both proteins.
We carried out competition experiments to assess
whether the WT PRRSV mRNA, the PRF-defective CC2
variant or a known PCBP2-binding RNA from poliovirus
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Figure 2. The C-rich region is essential for PRF. (A) A series of 3′ deletions were engineered into pDluc PRRSV/wt and transcribed mRNAs translated
in RRL in the presence of added nsp1 (1 M). Products were analysed by SDS-PAGE as detailed in the legend to Figure 1. The number below each lane
represents the length of the PRRSV-specific RNA sequence remaining downstream of the slippery sequence, of which 21 nt were sufficient for efficient
−2/−1 PRF in this assay. (B) Individual point mutations were introduced in and around the C-rich region (red) within pDluc PRRSV/wt and transcribed
mRNAs translated and analysed as above. The effect of each mutation on PRF is illustrated on the sequence below the gel, with a larger font size reflecting
a greater inhibition of PRF.
(internal ribosome entry signal [IRES] stem-loop IV; Ref.
36) could compete with the frameshift reporter mRNA for
PCBP2 binding in in vitro translation assays inRRL supple-
mented with nsp1 (Supplementary Figure S4). Consistent
with expectation, a dose-dependent reduction in frameshift-
ing efficiency was observed upon addition of short, un-
capped transcripts containing the WT PRRSV PRF sig-
nal or IRES stem-loop IV RNAs, but not with the control
mRNA with the C-rich stretch mutated.
Differential contribution of PCBP KH domains in PRF
PCBP family members have three KHdomains, an adjacent
pair (KH1 and KH2) close to the N-terminus and a third
(KH3) towards the C-terminus, separated from KH1 and
KH2 by an intervening sequence of variable length (Figure
3D). To test the involvement of individual KH domains in
PRF, amino acid substitutions (toGDDG)were introduced
within the conserved, hallmark GxxG loop in each domain,
which forms part of the RNA binding domain. These mu-
tations have been shown previously to abolish RNA bind-
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Figure 3. A requirement for poly(C) binding proteins in PRRSV −2/−1
PRF. (A) In vitro translation of pDluc PRRSV/wt mRNA in RRL alone
(wt), or in the presence of PCBP2 alone (0.7 M), nsp1 (from 0.1 to 1
M) or both proteins (PCBP2, 0.7 M; nsp1 from 0.1 to 1 M). A con-
trol translation was supplemented with PCBP2 dilution buffer (DB). (B) In
vitro translation of pDluc PRRSV/wt mRNA in WG extract in the pres-
ence of the indicated concentrations of nsp1 (M), PCBP2 (M) or both
proteins (PCBP2, from 0.5 to 1.5M; nsp1, 1M). A control translation
of pDluc PRRSV/wt mRNA in RRL is also shown. (C) In vitro transla-
tion in WG extract of pDluc PRRSV/wt mRNA in the presence of nsp1
(1 M) with added PCBP1, 2, 3 or 4 (at 0.5 and 1 M), hnRNPK (1 M)
or DB. Note PCBP3s were of mouse origin, with PCBP3 corresponding
to accession number NM 021568.2 and PCBP3* to XM 006513919.2. (D)
Multidomain structure of the PCBP family showing location of KH do-
mains (numbered with respect to human sequence) and secondary struc-
ture of individual KH domains. Adapted from Refs. (25 and 26).
ing activity of the individual domain without compromis-
ing its stability (37). As shown in Figure 5A and B, muta-
tion of the KH2 domain of PCBP1 or PCBP2 had little, if
any, effect on frameshifting, whereas the KH3 domain mu-
tation essentially abolished trans-activation. The KH1 do-
main mutation had a more varied phenotype. With PCBP1,
frameshift-stimulation was greatly reduced, but for PCBP2,
−2 PRF was diminished four-fold, but full activity in −1
PRF was retained. Further, whilst addition of PCBP1KH1m
or PCBP1KH3m alone was unable to stimulate PRF, when
Figure 4. Synergistic binding of nsp1/PCBP to the PRRSV mRNA.
(A) EMSA analysis of binding of nsp1, PCBP1 or PCBP2 (alone or in
combination) to a short (58 nt) 32P-labelled in vitro transcript containing
the PRRSV PRF signal. After incubation at 30◦C for 10 min, reactions
were loaded onto a 4% non-denaturing polyacrylamide gel and, following
electrophoresis, the gel was fixed, dried and subjected to autoradiography.
Numbers below lanes show fold molar excess of protein(s) with respect to
the radiolabelled RNA (10 nM). In lanes BSB, DB and W, RNA was in-
cubated alone with band-shift buffer, protein dilution buffer or water, re-
spectively (see ‘Materials and Methods’ section). (B) The composition of
RNA–protein complexes was investigated by supershift assay. Complexes
were prepared with 10 nM RNA and a 50-fold molar excess of nsp1 (N)
and PCBP2 (P2) and subjected to EMSA directly (N, P2, NP2), or after
incubation with monoclonal (mono) or polyclonal (poly) antisera raised
against PCBP2 (P2, mono) or nsp1 (N, mono or poly). As controls,
the radiolabelled RNAprobe was incubated with either DB, the P2mono
or the N poly.
added together, a partial restoration of both −2 and −1
PRF (to about 20% of the WT value) was observed (Fig-
ure 5C). Note that in all assays, frameshift-stimulation re-
mained dependent upon addition of nsp1 (Figure 5D).
From the lack of effect of the KH2 mutation on PRF,
we conclude that interaction of this domain with RNA
does not occur (or is unnecessary for PRF) and that mu-
tations within the GxxG loop of KH2 do not compromise
the specific interaction with nsp1. However, the KH1 and
KH3 mutations likely modify the interaction of the pro-
tein with RNA, and conceivably, with nsp1. EMSA analy-
sis confirmed the predicted effects on RNA binding, which
was reduced in the case of PCBP2KH1m, abolished with
PCBP2KH3m and largely unaffected for PCBP2KH2 (Fig-
ure 5E). Similar results were seen with PCBP1 (Supple-
mentary Figure S5). To assess the capacity of the various
PCBPs to bind nsp1 independently of RNA, a pull-down
assay was utilized (Supplementary Figure S6). Here, im-
mobilized GST-nsp1 was incubated with individual His-
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Figure 5. Role of PCBP1/2 KH domains in PRRSV PRF. (A) In vitro translation in WG extract of pDluc PRRSV/wt mRNA in the presence of nsp1
(1 M) and PCBP1, PCBP2 or PCBP1 KH domain mutants (P1 KH1-3m; 1 M). DB is dilution buffer. (B) Analysis of PCBP2 KH domain mutants,
details as in panel (A). (C) Compensatory effect on −2/−1 PRF of supplementing a WG translation with both PCBP1 KH1m and PCBP1 KH3m, details
as in panel (A). (D) Individual PCBP1/2 KH domain mutants do not stimulate PRF in the absence of nsp1, details as in panel (A). (E) EMSA analysis
of PCBP2 KH domain mutants. Binding of the KH domain mutants to the PRRSV RNA (10 nM; details in Figure 4) was investigated in the absence or
presence of added nsp1 (1 M).
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Figure 6. Spacer length is critical to PRRSV PRF magnitude and direc-
tion. (A) The spacer sequence separating slippery sequence and C-rich re-
gion of pDluc PRRSV/wt mRNA (underlined in blue) was varied from
4 to 13 nt (from WT [wt] of 10 nt, asterisked) as indicated. Where nec-
essary, the Fluc reading frame reporting −2 PRF was maintained by in-
serting one or two additional nucleotides immediately downstream of the
inserted PRRSV sequences in pDluc. (B) RNAs were translated in WG in
the presence of nsp1 (1 M) and PCBP1 or PCBP2 (1 M). Products
were analysed as in Figure 1.
tagged PCBPs and, after a detergent wash, bound protein
was eluted for analysis by immunoblotting. In comparison
to WT PCBP2, the binding of PCBP2 bearing any of the
three KH domain mutations to GST-tagged nsp1 was un-
affected, indicating that the effects on PRF are related to
changes in RNA binding rather than a reduced capacity to
associate with nsp1. Indeed, PCBPs 1–4 all bound nsp1
in this assay, thus the inability of PCBP4 to trans-activate
PRF at the PRRSV signal has some other explanation. Im-
portantly, GST-tagged nsp1 RBM was able to pull-down
PCBP2, indicating that the defect in this mutant is not in
the capacity to associate with its protein partner.
Mechanistic insights into protein-stimulated ribosomal
frameshifting
Spacing. A hallmark of RNA structure-dependent PRF
signals is the necessity to maintain a precise spacing be-
tween slippery sequence and stimulatory RNA to position
the ribosome appropriately at the slip-site (38,39). The im-
portance of spacing in PRRSV frameshifting was assessed
in WG translations programmed with reporter mRNAs
with spacer lengths of 4–13 nt (Figure 6). Efficient PRF
was seen over a narrow range (9–11 nt), with shorter spacers
leading preferentially to−2 PRF and longer spacers prefer-
entially to −1 PRF. This pattern of frameshifting is highly
reminiscent of that observed with stimulatory RNAs and
suggests that the nsp1/PCBP complex functionally mim-
ics such RNAs. The optimal spacer length was subtly differ-
ent for the twoPCBPs, withmaximal PRF (−2 and−1) seen
at longer spacer lengths for added PCBP1 compared with
PCBP2. Thus the capacity of the various PCPBs to promote
frameshifting into a particular reading frame is likely set by
the position and/or conformation of the protein complex
on the template, affected by subtle differences in the posi-
tion of KH domains within the proteins which influences
‘effective’ spacer length.
Pausing. Ribosome pausing at structured RNA stimula-
tors of PRF has been widely documented and may play a
mechanistic role (2). We tested whether the nsp1/PCBP2
complex could also induce pausing by cloning the PRRSV
signal (with a defective slippery sequence) in-frame within
a reporter gene and translating in vitro derived mRNAs in
the WG system. The extent of pausing was estimated by
comparing the levels of a translational intermediate cor-
responding to pausing at a bound nsp1/PCBP2 complex
with that of the full-length polypeptide produced during a
time course in which translation was synchronized by the
addition of edeine, a potent inhibitor of initiation, 5 min af-
ter the start of the reaction. A control mRNAwas prepared
from plasmid template linearized at the position of the in-
serted PRRSV signal to serve as a pause marker. As can be
seen in Figure 7, pausing was clearly evident in the presence
of nsp1/PCBP2, but far less so with either protein alone,
or on an mRNA lacking the C-rich region. The appearance
of the pause product was transient (albeit visible over sev-
eral minutes), consistent with its identity as a genuine in-
termediate rather than a dead-end product. In Figure 7C,
further pausing assays were carried out to examine the ac-
tivity of the PCBP2KH domain mutants (in the presence of
nsp1). We found a positive correlation between the extent
of pausing observed and the activity of the three mutants
in specific RNA binding, namely a little for PCBP2KH1m,
close to WT levels for PCBP2KH2m and much less pausing
for PCBP2KH3m.
DISCUSSION
A role for PRRSV nsp1 protein in PRF was the first de-
scription of a protein trans-activator of this process (19).
Here, we show that the active frameshift-stimulatory ele-
ment in fact comprises a complex of viral nsp1 and a cellu-
lar poly(C) binding protein. PCBPs have been shown to reg-
ulate gene expression at multiple levels, including transcrip-
tion, mRNA processing, mRNA stabilization and transla-
tion (reviewed in Refs. 25,26). Hitherto, a role for PCBPs
in protein synthesis has been limited to translation initia-
tion, mostly in the recruitment of ribosomes to viral IRESes
(see Ref. 40). Their activity in stimulating PRF in PRRSV
is the first example of a role for PCBPs in modulating trans-
lational elongation.
The induction of PRF by the nsp1–PCBP complex has
clear parallels with cis-acting structured RNA stimulators,
including the capacity to induce a ribosomal pause and the
necessity for maintaining a precise distance between slip-
pery sequence and stimulatory element. In RNA structure-
dependent PRF, interaction of the stimulatory RNA with
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Figure 7. Ribosomal pausing at the PRRRSV−2/−1 PRF signal. (A) The PRRSVWT (WT) C-rich region with amutated slippery sequence (as indicated)
was cloned into plasmid pPS0 (28) to generate plasmid pPS0/WT. A control plasmid (pPS0/CC2) additionally contained mutations in the C-rich region
(see text). (B) RNAs derived from AvaII-cut pPS0/WT or pPS0/CC2 were translated in WG extract at 18◦C for 5 min prior to addition of edeine to 5
M. Aliquots were removed at various times post-edeine addition, translation stopped and products resolved by 12% SDS-PAGE. The expected size of the
ribosomal pause product (pause) was marked by translating an mRNA produced from XhoI-cleaved pPS0. Translations were supplemented with 1 M
nsp1, PCBP2 or both proteins as indicated. (C) Ribosomal pausing assays were carried out as described in panel (B) above. Here, AvaII-cut pPS0/WT
mRNA was translated in WG extract supplemented with 1 M nsp1 and the KH domain mutants of PCBP2, as indicated.
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the ribosome impairs movement of the small subunit head
during translocation, destabilizing the hybrid state and el-
evating energy barriers corresponding to subsequent sub-
steps of translocation (15–17). Completion of translocation
is accelerated by slippage of tRNAs into the −1 frame, thus
promoting PRF. At the PRRSV signal, the bound nsp1–
PCBP complex would also be in close proximity to a ribo-
some actively decoding the slippery sequence, facilitating
interactions between them. In this light, itmay be significant
that in pull down assays, nsp1 has been shown to interact
with rpS14 (34), a protein immediately adjacent to a com-
ponent (rpS3) of the putative ribosome-associated mRNA
unwinding activity (13) and PCBP1 is known to interact
with RACK1 (41), a ribosome-associated protein located
close to the mRNA entry channel. Details of the molecular
interactions that take place upon encounter of elongating
ribosomes remain to be determined.
The geometry and stoichiometry of the nsp1–PCBP
complex on the PRRSV mRNA is uncertain and diffi-
cult to predict. Nsp1 exists as a dimer in solution (32),
PCBPs have been shown to be capable of homo- and hetero-
multimerization and RNA binding by PCBPs could reflect
interaction with single or multiple KH domains (42–44).
Binding assays with optimized RNA targets generated by
in vitro SELEX have revealed that a tandem array of three
C-patchesmaximizes PCBP2 binding to its RNA target (45)
and several established PCBP binding sites contain three or
more C-patches (33,46). However, the sequence motifs im-
plicated in PCBP binding from gene expression analysis of
human cells (47,48) and Caenorhabditis elegans (49) com-
prise predominantly two adjacent C-rich patches, although
it is not known how strongly PCBPs bind to these targets,
nor whether any other cellular proteins participate in the in-
teractions. TheEMSAdata presented here reveal that alone,
PCBP1 and PCBP2 bind weakly to the PRRSV C-rich re-
gion (which has two C-patches), requiring nsp1 for stable
binding. Similarly, nsp1 binds RNA very weakly, but is
evident in complexes (with PCBPs) from supershift assays.
Stable complex formation on the mRNA thus likely de-
pends upon conformational changes in one or both molec-
ular partners and potentially, direct contact between nsp1
and mRNA. In support of the latter, we found that amino
acid substitutions in the putative RBM) of nsp1 greatly
weakened the association of the complex with RNA, with-
out apparent effect on the interaction with PCBP2. Yeast
two-hybrid studies (35) have shown that the reciprocal in-
teraction of nsp1 and PCBP2 requires the C-terminus
of nsp1, including the protease domain (PLP1) and C-
terminal extension, and the KH2 domain of PCBP2. In
light of this, we hypothesize that the association of nsp1
with KH2 would not preclude binding of nsp1 to RNA.
An alternative interpretation is that nsp1 RBM fails to in-
duce a conformational change in PCBPs necessary for sta-
ble RNA association.
Our model for PRRSV −2/−1 PRF is that PCBPs inter-
act with the PRRSV mRNA through KH1 and KH3, with
each domain contacting one of the two C-patches (CCCA
and CUCC) within the C-rich region. The KH2 domain it-
self is not associated with the RNA, serving rather to bind
nsp1, with the complex poised to subvert the elongating ri-
bosome. In its capacity to stall ribosomes, the nsp1–PCBP
complex joins a growing list proteins that have been shown
to modulate the elongation step of protein synthesis. These
include Stm1 of Saccharomyces cerevisiae, which inhibits
translation after 80S formation (50), the fragile X mental
retardation protein, which reversibly stalls ribosomes on its
targetmRNAs (51) by binding directly to the ribosome (52),
the HIF-1 mRNA-associated cytoplasmic polyadenyla-
tion element binding protein 2, which binds eEF2 and slows
elongation (53) and the PUF-Ago-eEF1A complex that at-
tenuates elongation after the nascent peptide emerges from
the ribosomal exit tunnel (54). Stalling of ribosomes by the
nsp1–PCBP complex, perhaps as a consequence of a direct
interaction with the unwinding centre of the small subunit,
could promote PRF in a manner similar to that described
for structured RNA stimulators.
Not all PCBPs were capable of stimulating PRF. The lack
of activity of PCBP4 and hnRNP K/J is potentially a con-
sequence of differences in overall size and domain organi-
zation. PCBP1, 2 and 3 are globally similar, with KH do-
mains located at analogous positions in the protein, whereas
the linker separating KH2 and KH3 is shorter in PCBP4
and much longer in hnRNP K/J (Figure 3D). These dif-
ferences did not affect association of PCPB4 with nsp1,
but could affect the strength of binding of individual KH
domains to RNA or alternatively, preclude generation of
a correctly oriented or positioned complex on the mRNA.
With the KH domain mutants of PCBP1 and PCBP2, we
largely observed an excellent correlation between activity
in RNA binding, ribosomal pausing and the capacity to
induce PRF. However, we saw differential activity in PRF
of the KH1 domain mutants of PCBP1 and PCBP2, with
the former barely active yet the latter retaining function
in promoting −1 PRF, but with reduced −2 PRF. When
RNA association was examined by EMSA, PCBP1KH1m
and PCBP2KH1m bound to the PRRSV RNA with simi-
lar affinity and in an nsp1-dependent manner, although
binding was noticeably reduced in comparison to the WT
proteins. This suggests that PCBP1KH1m and PCBP2KH1m
still associate with the RNA, but the stability, conforma-
tion or position of the complex may be changed such that
only in the case of PCBP2KH1m is PRF possible, and only
−1 PRF (which is the predominant frameshift event for
WT PCBP2 at the natural spacing distance). As noted in
the ‘Results’ section, compensatory activity in PRF was de-
tected upon mixing the individually inactive PCBP1KH1m
and PCBP1KH3m, suggesting that two (or more) PCBPs can
cooperate to stimulate frameshifting. The differential activ-
ity of PCBP1KH1m and PCBP2KH1m could reflect an altered
capacity to homo-oligomerize.
The trans-activation of −2/−1 PRF by nsp1/PCBP
has intriguing parallels with a recently described trans-
lational readthrough event in human vascular endothe-
lial growth factor A (VEGFA) mRNA (55). Here, low-
frequency stop codon readthrough at the end of the pro-
angiogenic VEGFA coding sequence appends an additional
22 amino acids to the C-terminus, generating the VEGF-
Ax isoform which possesses anti-angiogenic activity. The
readthrough event is promoted by the binding of hnRNP
A2/B1 to a recognition element 10 nt downstream of the
recoded VEGFA stop codon. Similar to PCBPs, hnRNP
A2/B1 is known to associate with nascent cellular RNAs
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and influence their localization, maturation and function
(56). How it acts to stimulate readthrough is unknown, but
it is striking that both hnRNPA2/B1 and the nsp1/PCBP
complex promote their respective recoding events from a
similar distance 3′ of the ribosome, suggesting that theymay
contact the ribosome directly. How they subvert translation
likely differs in each case as we were unable to uncover any
stop codon readthrough activity of the nsp1/PCBP2 com-
plex (Supplementary Figure S1).
Our description of a role for PCBPs in ribosomal
frameshifting adds to a growing number of examples of vi-
ral subversion of PCBP function. In the best characterized
system, poliovirus, the capacity of PCBPs to associate at
two discrete genomic RNA locations and in concert with
different protein partners is critical to almost all aspects of
the virus replication cycle (reviewed in Ref. 57). Whether
such complex regulatory circuits operate during PRRSV
replication and transcription remains to be determined.
PCBP2 has been shown to associate with the 5′ untrans-
lated region of the PRRSV genome and may be involved
in genome replication or translation initiation (34,35). Fur-
thermore, the relative abundance and location of PCBPs in
the cytoplasm of infected cells could be important in de-
termining the precise ratio of non-frameshifted (full-length
nsp2) and trans-frame (nsp2TF, nsp2N) products at various
stages of the replication cycle.
Presently, stop codon readthrough in VEGFA (55) and
PRF in PRRSV (19, this work) represent the only two ex-
amples of specific modulation of translational decoding (re-
coding) mediated by proteins. The participation of hnRNPs
in each case may reflect the versatility of these proteins in
linking sequence-specific nucleic acid binding with specific
protein–protein interactions and serving as a fulcrum for
multilateral molecular cross-talk (58). It seems highly un-
likely that protein-mediated recoding will be restricted to
the two present examples, given the plethora of hnRNPs
and other RNA binding proteins present in host and viral
proteomes.
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